Compare e l f Beauty Inc (ELF) vs TG Therapeutics Inc (TGTX) Price & Performance

ELF Beauty trades at $94.33, down 0.96% on the day, with a bullish technical outlook supported by moving averages. The company reported strong Q1 2027 results, beating EPS estimates with $1.75 versus $0.71 expected, driven by 36% sales growth from the Rhode brand and international expansion. Valuation metrics show a high P/E of 96.93, reflecting premium pricing for growth. Recent news highlights a $50 million tariff refund boosting profits and expansion into hair care products.

Outlook remains positive due to consistent revenue growth and raised guidance, but risks include high valuation dependence on acquisitions and organic unit declines. Analyst consensus is mixed with a $91.14 price target, suggesting cautious optimism amid execution risks.

TG Therapeutics (TGTX) trades at $49.66, up 1.02% on the day, with a bearish technical signal and recent earnings misses despite strong revenue growth. The company reported Q2 2026 revenue of $240 million and raised full-year BRIUMVI guidance to $950 million, but net income was impacted by manufacturing investments. Valuation ratios show a high P/E of 18.22 and EV/EBITDA of 56.26, while profitability metrics like ROE of 100.28% remain robust.

Outlook is mixed: strong product demand and raised revenue targets support growth, but earnings volatility and a bearish technical trend pose risks. Analyst consensus is bullish with an $63.75 price target, though legal investigations and competitive pressures require monitoring for stock investors.